All In MedTech

Device Trial Radar · NCT06163404

Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant

A Prospective, Multi-Center, Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant for Correction of Cartilaginous Nasal Septal Deviation

Last checked: Nov 19, 2026Latest source record: Mar 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

102

Actual

Start

Nov 1, 2023

Primary completion

Mar 2027

Study completion Jun 2027

Sponsor

Lead sponsor
Spirair, IncNot on our public-company list
Sponsor type
Industry
First posted
Dec 8, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Pilot study of bioabsorbable implant and delivery device for correction of septal deviation.

Conditions

  • Nasal Septal Deviation
  • Nasal Airway Obstruction

Interventions

  • Implantation of Spirair Nasal Device using the Spirair delivery system.Device

    The Spirair implant is designed to acutely correct cartilaginous septal deviation and maintain the cartilage in a corrected position for a duration sufficient to allow for cartilaginous remodeling.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Effectiveness EndpointTime frame: 3 Months
  2. Primary Safety EndpointTime frame: 3 Months

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Alabama Nasal and Sinus Center

    Birmingham, Alabama

  • Breathe Clear Institute

    Torrance, California

  • Kentuckiana Ear, Nose & Throat

    Louisville, Kentucky

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.